Sign In
Buy VTGN
$0.229
-0.0108 (-4.50%)
At Close: Jul 17, 2026
What to Know About Trading Penny Stocks in August
03:30pm, Saturday, 23'rd Jul 2022 PennyStocks
Check these tips out for trading penny stocks in August
The post What to Know About Trading Penny Stocks in August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
What to Know About Trading Penny Stocks in August
11:30am, Saturday, 23'rd Jul 2022
Check these tips out for trading penny stocks in August The post What to Know About Trading Penny Stocks in August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Dow Dips More Than 200 Points; Crude Oil Moves Lower
06:59pm, Friday, 22'nd Jul 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Friday.
The Dow traded down 0.67% to 31,821.63 while the NASDAQ fell 2.09% to 11,807.11. The S&P
Nasdaq Drops Around 200 Points; Hanger Shares Spike Higher
04:49pm, Friday, 22'nd Jul 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Friday.
The Dow traded down 0.19% to 31,976.14 while the NASDAQ fell 1.65% to 11,860. The S&P a
This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday's Mid-Day Session
04:49pm, Friday, 22'nd Jul 2022 Benzinga
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Yoshitsu Co., Ltd (NASDAQ: TKLF) jumped 48
Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2022
02:06pm, Friday, 22'nd Jul 2022 Benzinga
Upgrades
For UDR Inc (NYSE:UDR), Jefferies upgraded the previous rating of Hold to Buy. UDR earned $0.55 in the first quarter, compared to $0.47 in the year-ago quarter. At the moment, the stock has a
VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q4 2022 Results - Earnings Call Transcript
10:14pm, Thursday, 23'rd Jun 2022
VistaGen Therapeutics, Inc. (NASDAQ:VTGN ) Q4 2022 Earnings Conference Call June 23, 2022 5:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Execut
VistaGen Therapeutics, Inc. (VTGN) Reports Q4 Loss, Misses Revenue Estimates
09:35pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
VistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of -33.33% and 88.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
VistaGen Therapeutics, Inc. (VTGN) Reports Q4 Loss, Misses Revenue Estimates
07:15pm, Thursday, 23'rd Jun 2022
VistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of -33.33% and 88.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
VistaGen Therapeutics to Report Fiscal Year 2022 Financial Results on June 23, 2022
08:30am, Friday, 17'th Jun 2022
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--VistaGen Therapeutics, Inc. (NASDAQ: VTGN) a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the t
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform t
Hot Penny Stocks For Your Buy List This Month? 3 to Watch
12:26am, Wednesday, 01'st Jun 2022 PennyStocks
Which penny stocks are you watching in June?
The post Hot Penny Stocks For Your Buy List This Month? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hot Penny Stocks For Your Buy List This Month? 3 to Watch
08:26pm, Tuesday, 31'st May 2022
Which penny stocks are you watching in June? The post Hot Penny Stocks For Your Buy List This Month?
Nurix Therapeutics, Inc. (NRIX) Soars 14.5%: Is Further Upside Left in the Stock?
09:20am, Tuesday, 31'st May 2022 Zacks Investment Research
Nurix Therapeutics, Inc. (NRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t
VistaGen to Participate in Upcoming June Investor Conferences
08:30am, Friday, 27'th May 2022
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the
